When was rybelsus fda approved?

When did the FDA approve Rybelsus (semaglutide)?

Rybelsus (oral semaglutide) was approved by the U.S. Food and Drug Administration (FDA) on September 12, 2019. [1]

What was it approved for?

The FDA approval was for treatment of adults with type 2 diabetes to improve glycemic control (as indicated on the FDA label for Rybelsus). [1]

Was it the same approval date as other semaglutide products?

No. Rybelsus is the oral formulation of semaglutide. (The injectable semaglutide product, Ozempic, was approved earlier than Rybelsus.)

Sources:
[1] https://www.drugs.com/history/rybelsus.html